Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease study.

RATIONALE Basic research implicates alveolar endothelial cell apoptosis in the pathogenesis of chronic obstructive pulmonary disease (COPD) and emphysema. However, information on endothelial microparticles (EMPs) in mild COPD and emphysema is lacking. OBJECTIVES We hypothesized that levels of CD31(+) EMPs phenotypic for endothelial cell apoptosis would be elevated in COPD and associated with percent emphysema on computed tomography (CT). Associations with pulmonary microvascular blood flow (PMBF), diffusing capacity, and hyperinflation were also examined. METHODS The Multi-Ethnic Study of Atherosclerosis COPD Study recruited participants with COPD and control subjects age 50-79 years with greater than or equal to 10 pack-years without clinical cardiovascular disease. CD31(+) EMPs were measured using flow cytometry in 180 participants who also underwent CTs and spirometry. CD62E(+) EMPs phenotypic for endothelial cell activation were also measured. COPD was defined by standard criteria. Percent emphysema was defined as regions less than -950 Hounsfield units on full-lung scans. PMBF was assessed on gadolinium-enhanced magnetic resonance imaging. Hyperinflation was defined as residual volume/total lung capacity. Linear regression was used to adjust for potential confounding factors. MEASUREMENTS AND MAIN RESULTS CD31(+) EMPs were elevated in COPD compared with control subjects (P = 0.03) and were notably increased in mild COPD (P = 0.03). CD31(+) EMPs were positively related to percent emphysema (P = 0.045) and were inversely associated with PMBF (P = 0.047) and diffusing capacity (P = 0.01). In contrast, CD62E(+) EMPs were elevated in severe COPD (P = 0.003) and hyperinflation (P = 0.001). CONCLUSIONS CD31(+) EMPs, suggestive of endothelial cell apoptosis, were elevated in mild COPD and emphysema. In contrast, CD62E(+) EMPs indicative of endothelial activation were elevated in severe COPD and hyperinflation.

[1]  Chantal M Boulanger,et al.  Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. , 2005, Journal of the American Society of Nephrology : JASN.

[2]  D. Giugliano,et al.  Endothelial microparticles correlate with erectile dysfunction in diabetic men , 2007, International Journal of Impotence Research.

[3]  J. Austin,et al.  Plasma carbonyls do not correlate with lung function or computed tomography measures of lung density in older smokers , 2008, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[4]  H. Kubo,et al.  Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility , 2012, Thorax.

[5]  D. Bluemke,et al.  Endothelial Microparticiples In Early Chronic Obstructive Pulmonary Disease (COPD): The Mesa COPD Study , 2011, ATS 2011.

[6]  N. Anthonisen.  Lessons from the Lung Health Study. , 2004, Proceedings of the American Thoracic Society.

[7]  Anthony P Reeves,et al.  Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study. , 2007, American journal of respiratory and critical care medicine.

[8]  Megha A. Parikh,et al.  Quantitative and Semiquantitative Measures of Regional Pulmonary Microvascular Perfusion by Magnetic Resonance Imaging and Their Relationships to Global Lung Perfusion and Lung Diffusing Capacity: The Multiethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease Study , 2013, Investigative radiology.

[9]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[10]  Richard A. Preston,et al.  Effects of Severe Hypertension on Endothelial and Platelet Microparticles , 2003, Hypertension.

[11]  G. Viegi,et al.  Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.

[12]  V. Peinado,et al.  Identification of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease. , 2006, American journal of respiratory cell and molecular biology.

[13]  R. Nieuwland,et al.  Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent , 2008, Thrombosis and Haemostasis.

[14]  G. Nickenig,et al.  Circulating CD 31 / Annexin V Apoptotic Microparticles Correlate With Coronary Endothelial Function in Patients With Coronary Artery Disease , 2005 .

[15]  P. J. Barnes,et al.  Systemic manifestations and comorbidities of COPD , 2009, European Respiratory Journal.

[16]  Patrice Darmon,et al.  Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. , 2002, Diabetes.

[17]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[18]  Josep Roca,et al.  Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[19]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[20]  C. Power,et al.  Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen , 1990, The Journal of experimental medicine.

[21]  L. Edwards,et al.  Changes in forced expiratory volume in 1 second over time in COPD. , 2011, The New England journal of medicine.

[22]  Nikos Werner,et al.  Circulating CD31+/Annexin V+ Apoptotic Microparticles Correlate With Coronary Endothelial Function in Patients With Coronary Artery Disease , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[23]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[24]  Jiaquan Xu,et al.  Deaths: preliminary data for 2011. , 2012 .

[25]  P. Hirth,et al.  Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. , 2000, The Journal of clinical investigation.

[26]  I. Petrache,et al.  Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice , 2005, Nature Medicine.

[27]  R. Lanzman,et al.  Correlation of Biexponential Diffusion Parameters With Arterial Spin-Labeling Perfusion MRI: Results in Transplanted Kidneys , 2013, Investigative radiology.

[28]  N. Voelkel,et al.  Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. , 2003, American journal of respiratory cell and molecular biology.

[29]  L. Horstman,et al.  Phenotypic assessment of endothelial microparticles in patients with heart failure and after heart transplantation: switch from cell activation to apoptosis. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  L. Horstman,et al.  Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. , 2003, Thrombosis research.

[31]  L. Horstman,et al.  Endothelial microparticles as markers of endothelial dysfunction. , 2004, Frontiers in bioscience : a journal and virtual library.

[32]  E. Hoffman,et al.  Endothelial Microparticles And Emphysema On CT Scan: The MESA COPD Study , 2012, ATS 2012.

[33]  P. Palange,et al.  Circulating haemopoietic and endothelial progenitor cells are decreased in COPD , 2006, European Respiratory Journal.

[34]  M. Gaxiola,et al.  Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. , 2000, Chest.

[35]  Dl Hoyert,et al.  National Vital Statistics Reports NCHS.pdf , 2012 .

[36]  W. Grossman,et al.  Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. , 2008, American journal of respiratory and critical care medicine.

[37]  A. Valipour,et al.  Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[38]  N. Taniguchi,et al.  Acrolein produces nitric oxide through the elevation of intracellular calcium levels to induce apoptosis in human umbilical vein endothelial cells: implications for smoke angiopathy. , 2006, Nitric oxide : biology and chemistry.

[39]  J. Stockman.  The Association of Pipe and Cigar Use With Cotinine Levels, Lung Function, and Airflow Obstruction: A Cross-sectional Study , 2011 .

[40]  D. Celermajer,et al.  Cigarette Smoking Is Associated With Dose‐Related and Potentially Reversible Impairment of Endothelium‐Dependent Dilation in Healthy Young Adults , 1993, Circulation.

[41]  Eric A. Hoffman,et al.  Percent emphysema, airflow obstruction, and impaired left ventricular filling. , 2010, The New England journal of medicine.

[42]  S. Glantz,et al.  Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. , 2008, Journal of the American College of Cardiology.

[43]  J. Roh,et al.  Increased Circulating Endothelial Microparticles and Carotid Atherosclerosis in Obstructive Sleep Apnea , 2010, Journal of clinical neurology.

[44]  Christopher S. Stevenson,et al.  Cigarette smoke disrupts VEGF165-VEGFR-2 receptor signaling complex in rat lungs and patients with COPD: morphological impact of VEGFR-2 inhibition. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[45]  J. Hankinson,et al.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.

[46]  J. Mezey,et al.  Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. , 2011, American journal of respiratory and critical care medicine.

[47]  E. Hoffman,et al.  Association Between High Density Lipoproteins (HDL) Cholesterol And CT Percent Emphysema. The MESA Lung Study , 2010, ATS 2010.

[48]  D A Lynch,et al.  Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. , 2001, American journal of respiratory and critical care medicine.

[49]  A. Minagar,et al.  Elevated plasma endothelial microparticles in multiple sclerosis , 2001, Neurology.

[50]  J. Connett,et al.  Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.

[51]  M. Cosio,et al.  Animal models of chronic obstructive pulmonary disease. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[52]  L. Horstman,et al.  High levels of circulating endothelial microparticles in patients with acute coronary syndromes. , 2003, American heart journal.